Skip to main content
TipRanks
Go Ultimate75% OFF

Bio View (BIOV) Financial Statements

0 Followers

Bio View Financial Overview

Bio View's market cap is currently ₪7.00M. The company's EPS TTM is ₪-95.00; its P/E ratio is -0.47; and it has a dividend yield of 0.05%. Bio View has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₪ 19.93M₪ 25.66M₪ 34.77M₪ 29.14M₪ 30.51M
Gross Profit₪ 8.75M₪ 15.56M₪ 21.38M₪ 16.67M₪ 17.59M
Operating Income₪ -7.80M₪ -2.88M₪ 766.00K₪ 1.15M₪ 2.95M
EBITDA₪ -7.19M₪ -943.00K₪ 2.93M₪ 2.61M₪ 4.45M
Net Income₪ -15.33M₪ -3.15M₪ 383.00K₪ 587.00K₪ 2.18M
Balance Sheet
Cash & Short-Term Investments₪ 7.22M₪ 10.94M₪ 17.11M₪ 19.44M₪ 19.22M
Total Assets₪ 19.89M₪ 33.62M₪ 41.95M₪ 41.93M₪ 40.02M
Total Debt₪ 2.79M₪ 1.98M₪ 3.51M₪ 4.06M₪ 4.61M
Net Debt₪ -2.13M₪ -6.24M₪ -12.18M₪ -15.38M₪ -14.62M
Total Liabilities₪ 10.47M₪ 10.68M₪ 14.65M₪ 13.65M₪ 12.86M
Stockholders' Equity₪ 9.41M₪ 22.95M₪ 27.30M₪ 28.28M₪ 27.16M
Cash Flow
Free Cash Flow₪ -3.11M₪ -3.14M₪ -121.00K₪ 511.00K₪ 2.59M
Operating Cash Flow₪ -3.06M₪ -3.11M₪ 153.00K₪ 968.00K₪ 3.25M
Investing Cash Flow₪ 255.00K₪ -1.54M₪ -1.67M₪ -567.00K₪ -740.00K
Financing Cash Flow₪ 425.00K₪ -2.95M₪ -2.68M₪ -1.61M₪ -268.00K

Currency in ILS

Bio View Earnings and Revenue History

-20M020M40M-100 %-50 %0 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Bio View Liabilities to Assets

015M30M45M24 %36 %48 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Bio View Cash Flow

-4M-2M02M4M201720182019202020212022202320242025OperatingInvestingFinancing

Bio View Forecast EPS vs Actual EPS

-0.200.30.50.811.3Q1 21Q2 21Q3 21EPS EstimateBeatMiss